Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study
Respirology · 2024
DOI: 10.1111/resp.14774 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Respirology, 2024. Verfasst von Jon R Konradsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Asthma, Anti-Asthmatic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart-Lung Foundation, Region Norrbotten, Region Stockholm.
Abstract (Originalsprache)
Background and Objective Uncontrolled asthma in patients treated for mild/moderate disease could be caused by non‐pulmonary treatable traits (TTs) that affect asthma control negatively. We aimed to identify demographic characteristics, behavioural (smoking) and extrapulmonary (obesity, comorbidities) TTs and the risk for future exacerbations among patients with uncontrolled asthma prescribed step 1–3 treatment according to the Global Initiative for Asthma (GINA).
Methods
Twenty‐eight thousand five hundred eighty‐four asthma patients (≥18 y) with a registration in the Swedish National Airway Register between 2017 and 2019 were included (index‐date). The database was linked to other national registers to obtain information on prescribed drugs 2‐years pre‐index and exacerbations 1‐year post‐index. Asthma treatment was classified into step 1–3 or 4–5, and uncontrolled asthma was defined based on symptom control, exacerbations and lung function.
Results
GINA step 1–3 included 17,318 patients, of which 9586 (55%) were uncontrolled (UCA 1–3). In adjusted analyses, UCA 1–3 was associated with female sex (OR 1.34, 95% CI 1.27–1.41), older age (1.00, 1.00–1.00), primary education (1.30, 1.20–1.40) and secondary education (1.19, 1.12–1.26), and TTs such as smoking (1.25, 1.15–1.36), obesity (1.23, 1.15–1.32), cardiovascular disease (1.12, 1.06–1.20) and depression/anxiety (1.13, 1.06–1.21). Furthermore, UCA 1–3 was associated with future exacerbations; oral corticosteroids (1.90, 1.74–2.09) and asthma hospitalization (2.55, 2.17–3.00), respectively, also when adjusted for treatment step 4–5.
Conclusion
Over 50% of patients treated for mild/moderate asthma had an uncontrolled disease. Assessing and managing of TTs such as smoking, obesity and comorbidities should be conducted in a holistic manner, as these patients have an increased risk for future exacerbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
- Department of Public Health and Clinical Medicine/The OLIN-Unit, Umeå University, Umeå, Sweden.
- Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
- Department of Health, Education and Technology, Luleå University of Technology, Luleå, Sweden.
- Division of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Caroline Stridsman
Förderung
- Swedish Heart-Lung Foundation
- Region Norrbotten
- Region Stockholm
- Freemason Child House Foundation
- the Konsul Th. C. Bergh's Foundation
- Swedish Asthma and Allergy Association's Research Foundation
- Paediatric Research Foundation of Astrid Lindgren Children's Hospital
- Hjärt-Lungfonden
Zitieren
APA
Konradsen, J. R., Selberg, S., Ödling, M., Sundbaum, J. K., Bossios, A., & Stridsman, C. (2024). Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study. Respirology. https://doi.org/10.1111/resp.14774
Vancouver
Konradsen JR, Selberg S, Ödling M, Sundbaum JK, Bossios A, Stridsman C. Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study. Respirology. 2024. doi:10.1111/resp.14774
BibTeX
@article{Konradsen2024,
author = {Konradsen, Jon R and Selberg, Stina and Ödling, Maria and Sundbaum, Johanna Karlsson and Bossios, Apostolos and Stridsman, Caroline},
title = {Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1–3 treatment: A nationwide asthma cohort study},
journal = {Respirology},
year = {2024},
doi = {10.1111/resp.14774}
}
EUVIMED